[1] |
WANG Mengke, GAN Chao, YUAN Yue, ZOU Jingyi, WANG Zhen, LI Shuyun, LV Haihong.
Correlation between type 2 diabetic kidney disease and trimethylamine-N-oxide
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(6): 661-670.
|
[2] |
WANG Xiaochuan, WANG Hanchao, YAO Yu, LI Li, HE Gaoyan, LI Bo, ZHU Tao.
Clinical features, risk factors and treatment of type 2 diabetes mellitus in patients with acute exacerbation of chronic obstructive pulmonary disease
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(4): 392-400.
|
[3] |
ZHOU Xin, WANG Zhi, DU Wenyu, LIU Zihan, LI Ying, DONG Zhanjun.
Research progress in clinical trials of new drugs and candidate drugs for type 2 diabetes mellitus
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(10): 1185-1193.
|
[4] |
MA Yan, TIAN Gaopeng, SHI Xingwen, SUN Ting, XIE Jingjing, ZHEN Donghu.
Correlation between 25(OH)D and metabolically related fatty liver in T2DM population
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 1018-1026.
|
[5] |
XIE Jingjing, YIN Hongtao, LIU Jinjin, SUN Weiming, ZHEN Donghu.
Baseline serum 25-hydroxyvitamin D3 levels and risk of metabolic syndrome: a prospective cohort study
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(6): 641-652.
|
[6] |
HOU Ruiying, GUO Lige, JIAO Weijie, DU Lei, WU Guiyue, ZHAO Xu.
Effects of Xiaokeshu recipe on levels of serum inflammatory factors in type2 diabetic rats and its mechanism
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(4): 377-382.
|
[7] |
BAI Jia, YANG Hong, LI Lingling, ZHANG Yangyang, YANG Ying, LV Haihong.
Study on the effect of vitamin D on diabetic neuropathy through mitochondrial/autophagy pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(2): 214-219.
|
[8] |
LI Chenhao, YU Xihua, YAN Wenhao, CHAI Yuxia, LI Yanyan, LI Kun, LI Zeyun.
Research progress on the relationship between pediatric epilepsy and vitamin D
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1299-1306.
|
[9] |
ZHAI Weiwei, YU Qiaoling, LIU Ping, QIU Bo, WU Huizhen.
Research progress of finerenone in the treatment of type 2 diabetes mellitus complicated with chronic kidney disease
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(9): 1067-1074.
|
[10] |
LU Senlin, LIU Xinyuan, WANG Jili, HUANG Xiaofei.
Research progress of virus-mediated gene therapy in type 2 diabetes mellitu
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(7): 800-807.
|
[11] |
DAI Hongyu, YANG Kun, HU Ruchun, ZHOU Hongmei, MA Peimin, HAO Qian.
Duration time and effectiveness of 0.25%ropivacaine for sciatic nerve block in patients with diabetes
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(11): 1278-1284.
|
[12] |
TANG Jiawei, MENG Xiangzhe, SUN Xuemin, LI Yuexuan, LIU Xue, WEI Hong.
Role of vitamin D and ACE2 in COVID-19
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(11): 1292-1298.
|
[13] |
ZHANG Quan, SHI Shiyuan, HAN Guihe.
1,25 dihydroxy vitamin D3 for immunoregulation in the treatment of spinal tuberculosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(7): 787-793.
|
[14] |
XU Yongxia, XIE Mingzhu, GONG Muxue, HUANG Jiaying, ZHAO Li, ZHU Defa.
Effects of 25(OH)D on islet β-cells function in the elderly with type 2 diabetes
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(9): 1021-1026.
|
[15] |
ZHAO Hailing, ZHANG Haojun, ZHAO Tingting, YAN Meihua, DONG Xi, MA Liang, LI Ping.
Association between the polymorphism of PNPLA2 gene and the risk of ischemic stroke in type 2 diabetic patients in Chinese Han Population
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(6): 664-669.
|